SCHEMBL3357757

SCHEMBL3357757

O=[N+]([O-])c1ccc2ccn(C3CCN(C4CCCC4)CC3)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HTR7 P34969 2/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
OPRK1 P41145 1/20 0.43
OPRL1 P41146 1/20 0.43
CDYL2 Q8N8U2 1/20 0.42
CDYL Q9Y232 1/20 0.42
CDY1; CDY1B Q9Y6F8 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
SLC18A3 Q16572 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12253684 0.85 HTR7 (0.55) NPC1ALDH1A1POLBMAPTRAB9A
SCHEMBL3353280 0.85 HTR7 (0.53) MAPTHTR7CDC7NOS3NOS1
SCHEMBL7805698 0.83 HTR7 (0.45) NPC1ALDH1A1POLBMAPTRAB9A
SCHEMBL3357415 0.81 HTR7 (0.42) NPC1ALDH1A1POLBMAPTRAB9A
SCHEMBL3358021 0.81 HTR7 (0.47) ALDH1A1POLBMAPTSMN1; SMN2HTR7
SCHEMBL3353526 0.81 CDC7 (0.43) NPC1ALDH1A1POLBMAPTRAB9A
SCHEMBL3359093 0.81 ALDH1A1 (0.41) ALDH1A1POLBMAPTSMN1; SMN2HTR7
SCHEMBL3353782 0.81 ALDH1A1 (0.42) ALDH1A1HTR7SIRT2CYP1A2CDC7
SCHEMBL3357611 0.81 CDC7 (0.43) NPC1ALDH1A1POLBMAPTRAB9A
SCHEMBL3355938 0.81 HTR7 (0.52) NPC1ALDH1A1POLBMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed